Mónica Roselló1, Francisco Martínez2, Sandra Monfort2, Sonia Mayo2, Silvestre Oltra2, Carmen Orellana2. 1. Unidad de Genética y Diagnóstico Prenatal, Hospital Universitari i Politècnic "La Fe", Avenida Campanar 21, 46009 Valencia, Spain. Electronic address: rosello_mpi@gva.es. 2. Unidad de Genética y Diagnóstico Prenatal, Hospital Universitari i Politècnic "La Fe", Avenida Campanar 21, 46009 Valencia, Spain.
Abstract
BACKGROUND: Nowadays the microarray technology allows whole-genome analysis with a high resolution and performance for the genetic diagnosis in any patient with intellectual disability or autism spectrum disorder. However in the immediate future, with the development of massive sequencing systems for application at clinical diagnosis, it will be necessary to have clinical criteria to guide studies. AIM: To perform an exhaustive clinical definition of patients with pathogenic copy number variations in order to establish the clinical criteria most suggestive of this kind of genomic rearrangements. METHOD: We designed and implemented a database to collect 190 different clinical variables (pregnancy, neonatal, facial dysmorphism, congenital anomalies, neurological features and family history) in a series of 246 patients, with developmental delay/intellectual disability. All cases were studied with array comparative genomic hybridization. RESULTS: We have found a pathogenic genomic imbalance in 73 patients. Frequency analysis of all clinical variables showed that growth disorder, abnormalities of hands, low-set ears and hypertelorism are the more frequent features among patients with genomic rearrangements. However other clinical features, such as genital abnormalities and aggressiveness, are more specifically associated with pathogenic copy number variations in spite of their low frequencies in the overall series, yielding higher statistical significance values than other traits. CONCLUSIONS: The genotype-phenotype comparison may be useful to set in the future the main clinical manifestations associated with deletions, duplications and unbalanced translocations. Theses analyses will improve the clinical indications and protocols to implement genomic arrays in the genetic study of patients with neurodevelopment disorders.
BACKGROUND: Nowadays the microarray technology allows whole-genome analysis with a high resolution and performance for the genetic diagnosis in any patient with intellectual disability or autism spectrum disorder. However in the immediate future, with the development of massive sequencing systems for application at clinical diagnosis, it will be necessary to have clinical criteria to guide studies. AIM: To perform an exhaustive clinical definition of patients with pathogenic copy number variations in order to establish the clinical criteria most suggestive of this kind of genomic rearrangements. METHOD: We designed and implemented a database to collect 190 different clinical variables (pregnancy, neonatal, facial dysmorphism, congenital anomalies, neurological features and family history) in a series of 246 patients, with developmental delay/intellectual disability. All cases were studied with array comparative genomic hybridization. RESULTS: We have found a pathogenic genomic imbalance in 73 patients. Frequency analysis of all clinical variables showed that growth disorder, abnormalities of hands, low-set ears and hypertelorism are the more frequent features among patients with genomic rearrangements. However other clinical features, such as genital abnormalities and aggressiveness, are more specifically associated with pathogenic copy number variations in spite of their low frequencies in the overall series, yielding higher statistical significance values than other traits. CONCLUSIONS: The genotype-phenotype comparison may be useful to set in the future the main clinical manifestations associated with deletions, duplications and unbalanced translocations. Theses analyses will improve the clinical indications and protocols to implement genomic arrays in the genetic study of patients with neurodevelopment disorders.
Authors: Sonia Mayo; Irene Gómez-Manjón; Francisco Javier Fernández-Martínez; Ana Camacho; Francisco Martínez; Julián Benito-León Journal: Int J Mol Sci Date: 2022-04-28 Impact factor: 6.208
Authors: I Maini; I Ivanovski; O Djuric; S G Caraffi; E Errichiello; M Marinelli; F Franchi; V Bizzarri; S Rosato; M Pollazzon; C Gelmini; M Malacarne; C Fusco; G Gargano; S Bernasconi; O Zuffardi; L Garavelli Journal: Ital J Pediatr Date: 2018-03-09 Impact factor: 2.638
Authors: Jin Sook Lee; Hee Hwang; Soo Yeon Kim; Ki Joong Kim; Jin Sun Choi; Mi Jung Woo; Young Min Choi; Jong Kwan Jun; Byung Chan Lim; Jong Hee Chae Journal: Ann Lab Med Date: 2018-09 Impact factor: 3.464
Authors: Francisco Martinez-Granero; Fiona Blanco-Kelly; Carolina Sanchez-Jimeno; Almudena Avila-Fernandez; Ana Arteche; Ana Bustamante-Aragones; Cristina Rodilla; Elvira Rodríguez-Pinilla; Rosa Riveiro-Alvarez; Saoud Tahsin-Swafiri; Maria Jose Trujillo-Tiebas; Carmen Ayuso; Marta Rodríguez de Alba; Isabel Lorda-Sanchez; Berta Almoguera Journal: NPJ Genom Med Date: 2021-03-25 Impact factor: 8.617